Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia

This publication has 29 references indexed in Scilit:

• The ratio of plasma high-density lipoprotein cholesterol to total and low-density lipoprotein cholesterol: age-related changes and race and sex differences in selected North American populations. The Lipid Research Clinics Program Prevalence Study.
  Circulation, 1985
• Effect of bezafibrate during 4.5 years of treatment of hyperlipoproteinaemia
  Atherosclerosis, 1985
• Receptor‐mediated uptake of hypertriglyceridaemic VLDL remnants by mouse macrophages in vitro
  Molecular Nutrition & Food Research, 1985
• The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.
  Circulation, 1984
• Influence of clofibrate, bile-sequestering agents and probucol on high-density lipoprotein levels
  The American Journal of Cardiology, 1983
• High-density lipoproteins: Epidemiologic profile and risks of coronary artery disease
  The American Journal of Cardiology, 1983
• The Mechanism of Action of Lipid-Lowering Drugs
  Angiology, 1982
• The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemia
  Atherosclerosis, 1980
• Atherogenesis: a postprandial phenomenon.
  Circulation, 1979
• Metabolic relationships among the plasma lipoproteins
  Journal of Clinical Investigation, 1972